The BI(G)MED Approach

High-Precision Immunogenetic Diagnosis

Before any therapeutic action, BI(G)MED relies on the precise identification of cellular and immune imbalances causing the disorders. To achieve this, it utilizes several specialized biological tools:

• Protein profile: This evaluates the patient’s immune, inflammatory, and nutritional status through markers such as IgM/IgG/IgA, CRP, transferrin, etc.
• Lymphocyte typing: A true snapshot of the immune system, it identifies lymphocyte subpopulations (T4, T8, B, NK, Treg) and their activity levels.
• Specific serologies: These help detect chronic low-grade infections (EBV, CMV, Borrelia, etc.) often involved in inflammatory, autoimmune, or degenerative pathologies.
• Genetic polymorphisms (especially HLA): These shed light on individual susceptibility to certain immune disorders.

Thanks to this cross-analysis of the immune terrain, BI(G)MED makes it possible to trace back to the root causes of imbalances, often even before symptoms appear.

A Regulatory Therapy, Based on Living Biology

Once the disruptive mechanisms are identified, the BI(G)MED approach offers customized regulatory formulas designed to restore the natural cellular self-regulation capabilities.

These formulas contain molecules naturally present in the body (including non-coding RNAs such as microRNAs or lncRNAs), selected based on validated scientific publications.

• They are administered at ultra-low doses (between 10⁻⁴ and 10⁻¹² Mol) to remain biomimetic: close to physiological cellular concentrations.
• They can act by activation or inhibition depending on the therapeutic need, to finely modulate the biological pathways involved.
• They are manufactured as magistral preparations, adapted to each patient.

This epigenetic and informational medicine does not act invasively. It stimulates natural repair and balance loops without disrupting fundamental processes.